Dermata Therapeutics, Inc. Logo

Dermata Therapeutics, Inc.

Medical dermatology company developing and commercializing OTC skin care products.

DRMA | US

Overview

Corporate Details

ISIN(s):
US2498451085
LEI:
Country:
United States of America
Address:
3525 DEL MAR HEIGHTS RD., #322, 92130 SAN DIEGO

Description

Dermata Therapeutics is a medical dermatology company that has shifted its strategic focus to developing and commercializing scientifically-backed over-the-counter (OTC) pharmaceutical products. The company leverages its proprietary Spongilla technology, which combines natural elements with FDA-listed OTC ingredients to create differentiated skin care solutions. Its initial product is a once-weekly acne kit, supported by clinical validation from its Phase 3 START-1 trial. Dermata plans to expand its portfolio with product candidates for other common skin conditions, such as psoriasis and seborrheic dermatitis, aiming to provide patients with accessible and effective treatments to manage their skin health.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Dermata Therapeutics, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Dermata Therapeutics, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Dermata Therapeutics, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Medivir Logo
A pharmaceutical company developing innovative drugs for cancer.
Sweden
MVIR
MediWound Ltd. Logo
Biopharmaceutical firm developing enzymatic therapeutics for non-surgical tissue repair.
United States of America
MDWD
Develops first-in-class therapies for oncology and autoimmune diseases.
South Korea
235980
Medrx Co.,Ltd. Logo
Develops pharmaceutical formulations using transdermal absorption technology.
Japan
4586
Medy-Tox Inc. Logo
Biopharmaceutical firm developing botulinum toxins, HA fillers, and dermocosmetics.
South Korea
086900
MeiraGTx Holdings plc Logo
A clinical-stage genetic medicine company treating eye, salivary, and CNS disorders.
United States of America
MGTX
Mendus Logo
Clinical-stage company developing immunotherapies to prevent tumor recurrence.
Sweden
IMMU
Merck & Co., Inc. Logo
A global biopharmaceutical company that develops medicines, vaccines, and animal health products.
United States of America
MRK
Mereo BioPharma Group plc Logo
Acquires and develops clinical-stage therapies for rare diseases.
United States of America
MREO
Mersana Therapeutics, Inc. Logo
A clinical-stage company developing antibody-drug conjugates (ADCs) for cancer.
United States of America
MRSN

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.